The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $126.79

Today's change+0.13 +0.10%
Updated December 24 1:05 PM EST. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $126.79

Today's change+0.13 +0.10%
Updated December 24 1:05 PM EST. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up (U.S.)$0.13

Thermo Fisher Scientific Inc closed up Wednesday by (U.S.)$0.13 or 0.10% to (U.S.)$126.79. Over the last five days, shares have gained 1.62% and are currently 2.30% off of the 52-week high. Shares have outperformed the S&P 500 by 2.33% during the last year.

Key company metrics

  • Open(U.S.) $126.99
  • Previous close(U.S.) $126.66
  • High(U.S.) $127.95
  • Low(U.S.) $126.68
  • Bid / Ask-- / --
  • YTD % change+13.87%
  • Volume665,521
  • Average volume (10-day)1,558,621
  • Average volume (1-month)1,460,453
  • Average volume (3-month)1,928,332
  • 52-week range(U.S.) $107.33 to (U.S.) $129.77
  • Beta0.94
  • Trailing P/E30.60×
  • P/E 1 year forward18.34×
  • Forward PEG1.48×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.47%
  • Trailing EPS(U.S.) $4.14
Updated December 24 1:05 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.30%

Based on its net profit margin of 10.30%, Thermo Fisher Scientific Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014Dec 31, 201312/31/2013
Revenue4,1714,3223,9043,467
Total other revenue--------
Total revenue4,1714,3223,9043,467
Gross profit1,9341,8471,6201,482
Total cost of revenue2,2382,4752,2841,985
Total operating expense3,5313,9743,0283,012
Selling / general / administrative1,2081,2391,202899
Research & development175184150105
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-9076-60723
Other operating expenses, total--------
Operating income640348876455
Interest income (expense), net non-operating-117-129-118-69
Gain (loss) on sale of assets--------
Other--------
Income before tax539237774378
Income after tax470279543343
Income tax, total69-4223135
Net income472279543342
Total adjustments to net income--------
Net income before extra. items470279543343
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items470279543343
Inc. avail. to common incl. extra. items472279543342
Diluted net income472279543342
Dilution adjustment----00
Diluted weighted average shares404403398371
Diluted EPS excluding extraordinary itemsvalue per share1.160.691.360.92
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share0.970.810.291.05